Both in Pharmaceuticals
TherapeuticsMD vs IGC Pharma
Over the past year TXMD returned +54.8% and IGC returned −53.8%; their daily moves had a correlation of 0.01.
TXMD +54.8% IGC −53.8%Growth of $1, one year, split-adjusted
| Metric | TXMD | IGC |
|---|---|---|
| Price | $1.78 | $0.1860 |
| Market cap | $20.6M | $19.2M |
| Today | −1.66% | −3.58% |
| 1 month | −11.4% | −34.0% |
| 6 months | −14.0% | −42.3% |
| Year to date | +9.2% | −33.9% |
| 1 year | +49.6% | −52.9% |
| Revenue growth (YoY) | −8.7% | −19.2% |
| Gross margin | 100.0% | 18.1% |
| Net margin | 17.8% | −1107.9% |
| P/E (TTM) | — | — |
| Price / sales | 6.3× | — |
| Net cash | $9.2M | -$728.0K |
| Dividend yield | — | — |
| Volatility (60d) | 33.8% | 63.5% |
| Short % of float | 0.2% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).